Tauriga Sciences Inc. Commences Development of Del
Post# of 4445
(Total Views: 80)
Posted On: 03/17/2021 10:04:18 AM
Tauriga Sciences Inc. Commences Development of Delta-8-THC Infused Version of Tauri-Gum
https://finance.yahoo.com/news/tauriga-scienc...c=fin-srch
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has commenced development of a Delta-8-Tetrahydrocannabinol (“Delta-8-THC” or “Delta-8”) infused version of Tauri-Gum™. Delta-8-THC infused products are legal when the ingredient has been derived from the Industrial Hemp plant (“Cannabis Sativa”) and does not contain more than 0.3% (1/333rdby dry weight composition) THC. The Company is focused on expanding both its product offerings and revenue opportunities, in a manner that is ethical, innovative, and fully compliant with Federal laws & regulations.
The Company will update shareholders at a future date, once additional details and specifics are available.
https://finance.yahoo.com/news/tauriga-scienc...c=fin-srch
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has commenced development of a Delta-8-Tetrahydrocannabinol (“Delta-8-THC” or “Delta-8”) infused version of Tauri-Gum™. Delta-8-THC infused products are legal when the ingredient has been derived from the Industrial Hemp plant (“Cannabis Sativa”) and does not contain more than 0.3% (1/333rdby dry weight composition) THC. The Company is focused on expanding both its product offerings and revenue opportunities, in a manner that is ethical, innovative, and fully compliant with Federal laws & regulations.
The Company will update shareholders at a future date, once additional details and specifics are available.
(0)
(0)Scroll down for more posts ▼